Idiopathic Parafoveal Telangiectasia
📧 Sign up to get email alerts when something new happens for Idiopathic Parafoveal Telangiectasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia [Phase 2]
This Phase 2 study evaluated high-dose ranibizumab (2.0 mg) for nonproliferative idiopathic parafoveal telangiectasia; the trial has complet…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial [Phase 1]
Phase 1 trial update showing completion of the RIPT study evaluating Ranibizumab for idiopathic parafoveal telangiectasia.